| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 112,563 | 87,583 | 99,721 | | Cost of Revenue | 80,558 | 58,841 | 74,703 | | | Gross Profit | 32,005 | 28,742 | 25,018 | | | Operating Expenses | | Research Development | 1,076 | 1,516 | 1,406 | | Selling General and Administrative | 28,184 | 21,308 | 17,167 | | Non Recurring | 27,887 |
-
|
-
| | Others | 2,344 | 987 |
-
| | | | Total Operating Expenses | 59,491 |
-
|
-
| | | | Operating Income or Loss | (27,486) | 4,931 | 6,445 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (101) | 2,137 | 594 | | Earnings Before Interest And Taxes | (27,587) | 7,068 | 7,039 | | Interest Expense | 2,094 | 1,156 | 1,109 | | Income Before Tax | (29,681) | 5,912 | 5,930 | | Income Tax Expense | 2,933 | 2,744 | 2,225 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (32,614) | 3,168 | 3,705 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (32,614) | 3,168 | 3,705 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($32,614) | $3,168 | $3,705 |
|
0.10% Nasdaq 
Income Statement
